vs

Side-by-side financial comparison of Ardent Health, Inc. (ARDT) and Sylvamo Corp (SLVM). Click either name above to swap in a different company.

Ardent Health, Inc. is the larger business by last-quarter revenue ($1.6B vs $890.0M, roughly 1.8× Sylvamo Corp). Sylvamo Corp runs the higher net margin — 3.7% vs 2.8%, a 0.9% gap on every dollar of revenue.

Goodlife Health Clubs is a chain of health clubs, with more than 80 locations in Australia.

Sylvamo Corp is a leading global manufacturer of sustainable paper and pulp products. Its core offerings include uncoated printing paper, packaging paper, and market pulp, serving office supplies, publishing, commercial printing, and packaging segments across North America, Europe, and Latin America.

ARDT vs SLVM — Head-to-Head

Bigger by revenue
ARDT
ARDT
1.8× larger
ARDT
$1.6B
$890.0M
SLVM
Higher net margin
SLVM
SLVM
0.9% more per $
SLVM
3.7%
2.8%
ARDT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARDT
ARDT
SLVM
SLVM
Revenue
$1.6B
$890.0M
Net Profit
$45.0M
$33.0M
Gross Margin
Operating Margin
5.8%
8.9%
Net Margin
2.8%
3.7%
Revenue YoY
-8.2%
Net Profit YoY
-59.3%
EPS (diluted)
$0.32
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARDT
ARDT
SLVM
SLVM
Q4 25
$1.6B
$890.0M
Q3 25
$1.6B
$846.0M
Q2 25
$1.6B
$794.0M
Q1 25
$1.5B
$821.0M
Q4 24
$970.0M
Q3 24
$1.4B
$965.0M
Q2 24
$1.5B
$933.0M
Q1 24
$905.0M
Net Profit
ARDT
ARDT
SLVM
SLVM
Q4 25
$45.0M
$33.0M
Q3 25
$-23.5M
$57.0M
Q2 25
$73.0M
$15.0M
Q1 25
$41.4M
$27.0M
Q4 24
$81.0M
Q3 24
$26.3M
$95.0M
Q2 24
$42.8M
$83.0M
Q1 24
$43.0M
Operating Margin
ARDT
ARDT
SLVM
SLVM
Q4 25
5.8%
8.9%
Q3 25
-0.1%
11.6%
Q2 25
7.4%
3.8%
Q1 25
5.0%
5.4%
Q4 24
11.2%
Q3 24
3.9%
15.5%
Q2 24
5.6%
13.1%
Q1 24
8.0%
Net Margin
ARDT
ARDT
SLVM
SLVM
Q4 25
2.8%
3.7%
Q3 25
-1.5%
6.7%
Q2 25
4.4%
1.9%
Q1 25
2.8%
3.3%
Q4 24
8.4%
Q3 24
1.8%
9.8%
Q2 24
2.9%
8.9%
Q1 24
4.8%
EPS (diluted)
ARDT
ARDT
SLVM
SLVM
Q4 25
$0.32
$0.81
Q3 25
$-0.17
$1.41
Q2 25
$0.52
$0.37
Q1 25
$0.29
$0.65
Q4 24
$1.91
Q3 24
$0.19
$2.27
Q2 24
$0.34
$1.98
Q1 24
$1.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARDT
ARDT
SLVM
SLVM
Cash + ST InvestmentsLiquidity on hand
$709.6M
$198.0M
Total DebtLower is stronger
$1.1B
$763.0M
Stockholders' EquityBook value
$1.3B
$966.0M
Total Assets
$5.3B
$2.8B
Debt / EquityLower = less leverage
0.84×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARDT
ARDT
SLVM
SLVM
Q4 25
$709.6M
$198.0M
Q3 25
$609.4M
$146.0M
Q2 25
$540.6M
$183.0M
Q1 25
$495.0M
$220.0M
Q4 24
$309.0M
Q3 24
$563.1M
$414.0M
Q2 24
$334.5M
$213.0M
Q1 24
$218.0M
Total Debt
ARDT
ARDT
SLVM
SLVM
Q4 25
$1.1B
$763.0M
Q3 25
$1.1B
$778.0M
Q2 25
$1.1B
$767.0M
Q1 25
$1.1B
$794.0M
Q4 24
$782.0M
Q3 24
$1.1B
$883.0M
Q2 24
$1.1B
$894.0M
Q1 24
$921.0M
Stockholders' Equity
ARDT
ARDT
SLVM
SLVM
Q4 25
$1.3B
$966.0M
Q3 25
$1.2B
$977.0M
Q2 25
$1.3B
$959.0M
Q1 25
$1.2B
$908.0M
Q4 24
$847.0M
Q3 24
$1.0B
$937.0M
Q2 24
$739.9M
$830.0M
Q1 24
$889.0M
Total Assets
ARDT
ARDT
SLVM
SLVM
Q4 25
$5.3B
$2.8B
Q3 25
$5.2B
$2.7B
Q2 25
$5.0B
$2.7B
Q1 25
$4.9B
$2.6B
Q4 24
$2.6B
Q3 24
$4.8B
$2.9B
Q2 24
$4.6B
$2.7B
Q1 24
$2.6B
Debt / Equity
ARDT
ARDT
SLVM
SLVM
Q4 25
0.84×
0.79×
Q3 25
0.88×
0.80×
Q2 25
0.87×
0.80×
Q1 25
0.93×
0.87×
Q4 24
0.92×
Q3 24
1.08×
0.94×
Q2 24
1.46×
1.08×
Q1 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARDT
ARDT
SLVM
SLVM
Operating Cash FlowLast quarter
$223.4M
$94.0M
Free Cash FlowOCF − Capex
$38.0M
FCF MarginFCF / Revenue
4.3%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
4.97×
2.85×
TTM Free Cash FlowTrailing 4 quarters
$44.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARDT
ARDT
SLVM
SLVM
Q4 25
$223.4M
$94.0M
Q3 25
$154.4M
$87.0M
Q2 25
$117.5M
$64.0M
Q1 25
$-24.8M
$23.0M
Q4 24
$164.0M
Q3 24
$89.7M
$163.0M
Q2 24
$115.0M
Q1 24
$27.0M
Free Cash Flow
ARDT
ARDT
SLVM
SLVM
Q4 25
$38.0M
Q3 25
$33.0M
Q2 25
$-2.0M
Q1 25
$-25.0M
Q4 24
$100.0M
Q3 24
$119.0M
Q2 24
$62.0M
Q1 24
$-33.0M
FCF Margin
ARDT
ARDT
SLVM
SLVM
Q4 25
4.3%
Q3 25
3.9%
Q2 25
-0.3%
Q1 25
-3.0%
Q4 24
10.3%
Q3 24
12.3%
Q2 24
6.6%
Q1 24
-3.6%
Capex Intensity
ARDT
ARDT
SLVM
SLVM
Q4 25
6.3%
Q3 25
6.4%
Q2 25
8.3%
Q1 25
5.8%
Q4 24
6.6%
Q3 24
4.6%
Q2 24
5.7%
Q1 24
6.6%
Cash Conversion
ARDT
ARDT
SLVM
SLVM
Q4 25
4.97×
2.85×
Q3 25
1.53×
Q2 25
1.61×
4.27×
Q1 25
-0.60×
0.85×
Q4 24
2.02×
Q3 24
3.41×
1.72×
Q2 24
1.39×
Q1 24
0.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons